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Abstract
Platelet-mediated clumping of Plasmodium falciparum infected erythrocytes is an adhesive
phenotype commonly found in field isolates that has previously been associated with severe
malaria. Here, clumping was assessed in 131 isolates from Malian children. The clumping
phenotype was seen in 6% (n=51) of uncomplicated malaria, 24% (n=51) of severe malaria, and
45% (n=29) of high parasitemia non-severe malaria isolates. Multivariate analysis indicated that
clumping was strongly positively associated with parasitemia (F1,122=24.1, p<0.001) but not with
disease category (F2,122=1.8, p=0.17). Therefore platelet-mediated clumping in Malian P.
falciparum isolates is primarily associated with high parasitemia and not with severe clinical
manifestations of malaria.
Introduction
Plasmodium falciparum, the most virulent of the parasites causing human malaria, has the
unique ability to sequester in the vasculature of diverse host organs.1 Sequestration resulting
from the adherence of erythrocytes that contain mature forms of P. falciparum (trophozoites
and schizonts) to the vascular endothelium occurs in all infections. However, several
adhesive phenotypes have been associated with severe pathological outcomes of malaria,
such as the formation of rosettes, and the sequestration of infected erythrocytes (IEs) in the
microvasculature of the brain and the placenta.1 Recently, it has been shown that some P.
falciparum IEs can bind platelets to form platelet-mediated clumps2, a cytoadherence
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phenomenon that has been associated with severe malaria in Kenya2 and Thailand3.
Although P. falciparum seems to use CD36 on the surface of platelets as a receptor for
platelet-mediated clumping of IEs2, nothing is known about the parasite proteins involved in
this cell-to-cell interaction. Here, we investigated the association between disease severity
and the platelet-mediated clumping phenotype of P. falciparum isolates from Malian
children.
Methods
Study site and field isolates
Parasite isolates were collected in Bandiagara, Mali, an area with intense seasonal
transmission of P. falciparum (up to 20-60 infected bites per person per month at the peak of
the July-December transmission season).4 The samples were collected as part of the
Bandiagara Malaria Project case-control study in which severe malaria cases were matched
by age, residence and ethnicity to uncomplicated malaria controls.5 Blood samples were
collected from children with malaria after informed consent from parents or guardians, and
all protocols received institutional review board approval. The WHO criteria for severe
malaria were applied6, although patients with hyperparasitemia (>500,000 parasites per
microlitre of blood) and no other symptoms or signs of severe disease were analysed as a
separate group. Previous studies indicate an excellent prognosis for children with non-severe
hyperparasitemia, and this category can therefore be considered as a form of uncomplicated
malaria with particularly high parasite densities.5 Uncomplicated malaria cases were
children with P. falciparum infection and fever but with no symptoms or signs of severe
malaria and no hyperparasitemia.
Parasite culture
Blood samples were depleted of lymphocytes via density centrifugation and then were
suspended in Glycerolyte and frozen to −70°C. Frozen samples were shipped to Edinburgh
where they were thawed by standard methods. Briefly, the isolates were diluted in a gradient
of salt solutions and washed in RPMI 1640 medium containing 2mM glutamine, 25mM
Hepes, 20 mM glucose and 25 μg/ml gentamicin (incomplete RPMI) before culturing in
complete RPMI (incomplete RPMI supplemented with 10% human AB serum). The
parasites were cultured in 3% CO2, 1% O2, 96% N2 at 37°C. Cultures were monitored by
Giemsa-stained thin smears for 18-36 hours, and only those with normal morphology that
matured to the pigmented-trophozoite stage were included in the study.
Clumping assays
Clumping was assessed when the parasites reached the mature pigmented trophozoite stage,
using methods described previously3 with minor modifications (described below). Briefly,
parasite cultures were suspended at 2% haematocrit in 10% platelet-rich plasma (PRP) from
an AB+ malaria-naïve donor (to avoid ABO compatibility problems) in incomplete RPMI
medium (final concentration 1×107 platelets per ml). 25 μg/ml of ethidium bromide was
added and the mixture was gently rotated for 30 minutes at room temperature. A wet
preparation was viewed on a fluorescence microscope and 500 infected red cells were
counted and scored for clumping, with 3 or more IEs adherent to each other constituting a
clump. The clumping frequency is expressed as the percentage of IEs in clumps out of 500
IEs counted. An aliquot of each culture was also set up with 10% platelet-poor plasma (PPP)
as described previously3, and clumping assessed as above, however no clumping was seen
in any sample in PPP.
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Rosetting assays
Rosette frequency was assessed by staining an aliquot of culture suspension with 25 μg/ml
of ethidium bromide. A wet preparation of the suspension (2% haematocrit) was viewed
with a fluorescence microscope and the number of mature-IEs binding 2 or more uninfected
erythrocytes was counted. The rosette frequency is the percentage of IEs in rosettes out of
200 IEs counted.
Statistical analysis
Univariate analysis was carried out using Statview (version 5, SAS Institute, Inc.).
Multivariate analysis was carried out using S-PLUS 6.0 (Release 1, Insightful Corp.), using
Generalized Linear Models (GLM). Since the response variables were proportions, and
therefore bound between 0 and 1, they were analysed using binomial errors with a logit
linear predictor,7,8 The percentages of infected erythrocytes forming clumps were analysed
as counts with binomial errors. Explanatory variables in the statistical model included blood
group, category of disease (severe, hyperparasitemia, and uncomplicated - as defined
above), % parasitemia, % rosetting, age and haemoglobin level. Models were fitted as
follows. All explanatory terms were fitted including interactions up to second order where
possible. Interactions including more than two terms (e.g. a third order interaction between
three explanatory terms) were not permitted due to small sample sizes. This would have
reduced residual degrees of freedom, making the model unstable, and would also have
increased the risk of incurring both type I and type II errors.7, 8 The statistical significance
of a term in a GLM with binomial errors was assessed by the change in deviance of the
model when the term was dropped from it. To correct for overdispersion, significance of a
term was assessed using an F ratio. Minimal models were obtained by step-wise deletion of
non-significant terms, using an α-value of 0.05.
Results
Clumping was assessed in 131 P. falciparum isolates from Malian children (51 from
children with uncomplicated malaria, 29 from children with non-severe hyperparasitemia
and 51 from children with severe malaria). The characteristics of the patients from which the
parasite isolates were derived are summarised in Table 1. The children in the three disease
categories did not differ significantly in age, however, the children with severe malaria had
lower haemoglobin levels than the other two groups and the children with uncomplicated
malaria had lower parasitemia levels than the other two groups (Table 1). The severe malaria
category comprised 16 children with unrousable coma (Blantyre coma score ≤2), 12 non-
comatose children with impaired consciousness or prostration, 14 children with repeated
seizures, 5 children with severe malarial anaemia (Hb <5 g/dl) and 4 children with assorted
other severe malaria syndromes (jaundice, haematuria, renal failure). 18 of the severe
malaria children had concomitant hyperparasitemia.
The clumping phenotype was seen in 28/131 (21.4%) of all isolates and there were
significant differences between clinical categories in the number of isolates showing
clumping. 3/51 (6%) of the uncomplicated malaria isolates formed clumps, 12/51 (24%) of
severe malaria isolates formed clumps and 13/29 (45%) of the non-severe hyperparasitemia
isolates formed clumps (χ2 =16.9, 2df, p<0.0001). The distribution of clumping frequencies
in the three disease categories is shown in Figure 1. Higher levels of clumping were seen in
the non-severe hyperparasitemia and severe malaria categories than the uncomplicated
malaria category (Kruskal Wallis test, p<0.001). Multivariate analysis indicated that
clumping was strongly positively associated with parasitemia (F1,122 = 24.1, p<0.001). The
apparent association between clumping and disease category shown above was directly due
to differences in the parasitemia in each category. Thus when parasitemia was included in
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the statistical model, disease category was a non-significant term (F2,122 = 1.8, p=0.17).
Patient age and haemoglobin were also non-significant terms in the model. Clumping was,
however, found to be negatively associated with rosette frequency (F1,122 = 5.8, p<0.001).
Rosette frequency itself was strongly associated with severe disease in this sample set
(uncomplicated malaria: median rosette frequency (RF) 3%, interquartile range (IQR)
0-15.0, non-severe hyperparasitemia: median RF 7%, IQR 2-16.8, severe malaria: median
RF 20%, IQR 10-36.3, Kruskal Wallis test p<0.0001), as has been observed previously in
isolates from African children.9,10 The analysis of factors affecting clumping was repeated
using a smaller dataset consisting only of severe disease cases, so that the effects of sub-
category of severe disease could be considered. The main findings were very similar,
however there were no significant differences in clumping between the subcategories of
severe disease (F4,43 = 1.08, p=0.38).
Discussion
The main finding of this study was that P. falciparum platelet-mediated clumping is not
associated with severe clinical manifestations of malaria, but is significantly associated with
high parasitemia, a result that differs from those reported previously from Kenya2 and
Thailand.3 The previous studies compared clumping in isolates from severe malaria cases
with that in isolates from uncomplicated malaria controls that had significantly lower
parasite burdens than the severe malaria cases.2,3 On multivariate analysis, the previous
studies found both high parasitemia and severe disease (cerebral malaria in Thai adults) to
be independently associated with clumping.2,3 In the present study, we were able to extend
the investigation of the effects of parasitemia and severe disease on clumping by including a
high parasitemia non-severe malaria control group. Our results indicate that parasitemia but
not disease category is the most significant factor in relation to clumping in P. falciparum
isolates from African children. These results highlight the fact that inclusion of non-severe
controls with high parasite burdens equivalent to those in severe cases might be of great
importance, not only for the study of clumping, but also in the investigation of other parasite
phenotypes associated with severe malaria in Africa.11,12,13 Non-severe hyperparasitemia
is a feature of malaria in children in semi-immune populations such as those found in sub-
saharan Africa, however in low transmission areas such as Thailand, such non-severe
hyperparasitaemic patients are rare and high parasitemia is highly predictive of severe
disease.14
One limitation of the study reported here is that, as in the previous Kenyan study2, the
analysis was carried out primarily with a mixed group of severe malaria syndromes. Larger
studies are needed to examine the association of clumping with specific sub-types of severe
disease, as done in Thailand where clumping was associated with cerebral malaria but not
with the multi-organ failure type of severe malaria.3 In the present study, clumping in
isolates from cerebral malaria cases (unrousable coma, n=16), did not differ significantly
from clumping in isolates from patients with other forms of severe disease (n=35). The
lower absolute numbers of platelet-mediated clumps found in our study are probably
explained by methodological differences (notably, in haematocrit and time of the reaction)
between this and the study carried out in Kenya2, although our methods are comparable to
those used in Thailand.3
Another possible limitation of the current study is that the isolates examined were all frozen
immediately after collection, and later thawed and cultured for 18-36 hours in vitro before
clumping was assessed. Previous work has shown that it is possible for P. falciparum
isolates to show different antigenic profiles after being frozen and thawed, however, the
majority of isolates show very similar antigenic profiles before and after freezing.15 In
addition, in a small study of twelve field isolates we found that rosette frequency, a
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virulence-associated phenotype9,16 that is mediated by the variant surface antigen
PfEMP1,17 is not affected by freezing. There was a very strong positive correlation between
the rosette frequency of fresh isolates compared to the rosette frequency of the same isolates
after freezing and thawing, r2=0.91, P<0.001, least squares regression, n=12). We therefore
think it is unlikely that the use of frozen isolates had a major impact on the results of this
study.
It is unclear whether the relationship between clumping and parasitemia shown here
represents a genuine biological phenomenon (ie isolates that grow to high parasitemia in
their human hosts do have higher clumping frequencies than those that only reach low
parasitemia) or whether it is merely a technical artefact of the assay (ie clumping is seen
more readily when the parasitemia of the culture is high). Preliminary experiments with P.
falciparum laboratory strains suggest that the latter is the most likely explanation (M. Arman
unpublished data). In future studies of clumping and disease severity it may be prudent to
control for the effect of parasitemia, either by using parasitemia-matched severe malaria
cases and uncomplicated malaria controls, or by diluting all isolates to a standard starting
parasitemia before performing the clumping assay.
Independently of the platelet-mediated clumping phenotype, there is evidence suggesting
that platelets may have an important role in the pathology of malaria. Platelet sequestration
has been described in the cerebral vessels of children who have died with severe malaria.18
Moreover, platelets have been involved in brain endothelial alterations induced by P.
falciparum in in vitro models.19 The fact that platelet-mediated clumping was previously
associated with severe malaria2,3 and the large size of the clumps found in vitro have lead to
the hypothesis that platelet-mediated clumps of P. falciparum IEs may contribute to disease
severity by increasing vascular resistance and causing local disturbance of blood flow.
Nevertheless, the association of clumping with high parasitemia but not with severe malaria
shown in the present study suggests that the interaction of IEs with platelets in the context of
clumping may not be a causative agent of severe disease. It will be important in future to try
and understand the way in which P. falciparum parasites are affected by the formation of
platelet-mediated clumps. In this regard, it is of interest to note that some studies have
demonstrated that platelets are able to inhibit the growth and maturation of P. falciparum
infected erythrocytes in vitro.20,21
In summary, the data from this study challenge the conclusions of previous work by
indicating the platelet-mediated clumping is associated with high parasitemia but not with
severe clinical manifestations of malaria. Further work is needed to examine the
relationships between clumping, parasitemia and disease severity in other areas, and to
understand the physiological effects of platelet-mediated clumping on P. falciparum.
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Fig 1.
The distribution of clumping frequencies in P. falciparum isolates from Malian children with
uncomplicated malaria, non-severe hyperparasitemia and severe malaria, The clumping
frequency is the percentage of mature pigmented-trophozoite infected cells in clumps of 3 or
more infected cells, out of 500 infected cells counted. The differences in clumping between
disease categories are statistically signifciant (P<0.001, Kruskal Wallis Test). IQR:
interquartile range.
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Table 1
Summary of patient characteristics
Disease category N Agea (months) Hba (g/dl) Pta,b (%)
Uncomplicated malaria 51 41.2
(27.4)
9.8
(2.5)
2.4
(1.5)
Non-severe hyperparasitemia 29 47.1
(28.1)
10.0
(2.3)
11.5
(6.2)
Severe malaria 51 34.8
(23.7)
8.2
(1.8)
7.3
(5.9)
P value c 0.12 0.0003 <0.0001
a
Mean (standard deviation)
b
Pt: parasitemia
cANOVA
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